Inside Philanthropy

Go beyond 990s.

Wellcome Trust

, |

OVERVIEW: Wellcome is a London-based global charitable foundation and one of the world’s largest funders of health research.

IP TAKE: Wellcome is one of the world’s largest health-research funders, backing ambitious work across Discovery Research, Climate and Health, Infectious Disease and Mental Health. It plans to spend £16 billion between 2022 and 2032 and maintains a detailed website, searchable grants database and frequently updated list of funding opportunities.

This is a transparent funder, but not an easy one. Wellcome does not entertain generic nonprofit pitches, even though many of its researcher awards and targeted calls are openly competitive. The real barriers are eligibility, institutional capacity, research leadership and fit with a tightly defined opportunity.

Universities, research institutes, academic medical centers and sophisticated global-health organizations are the strongest direct prospects. Individual researchers generally need institutional endorsement and must apply through their organization’s research administration office. Smaller nonprofits are more likely to succeed as consortium partners, contributing community relationships, implementation expertise, lived-experience knowledge, policy access or evidence translation.

Discovery Research offers recurring open schemes, while Wellcome’s other strategic programs rely more heavily on targeted calls. Grantseekers should monitor the live funding finder closely rather than treat each program as a standing competition. Wellcome Leap, launched in 2018, operates separately in the U.S. and funds bold, milestone-driven scientific and technological programs.

PROFILE: Wellcome Trust, one of the largest charitable foundations in the world, was established by the estate of Sir Henry Wellcome, a pharmaceutical entrepreneur, upon his death in 1936. Wellcome was a cofounder of Burroughs Wellcome & Co., which, following a series of mergers between 1995 and 2000, is now an integral part of the pharmaceutical giant GSK (GlaxoSmithKline). Based in London, the Wellcome Trust’s mission is to “support science to solve the urgent health challenges facing everyone.” Its Programs are Discovery Research, Climate and Health, Infectious Disease and Mental Health.

Funding flows through recurring researcher awards, time-limited calls, major institutional initiatives and, in some cases, invitation-only discretionary awards. Wellcome is not broadly invitation-only. Its principal Discovery Research awards and many targeted calls use published, competitive application processes. However, it does not accept generic proposals outside its named schemes and calls, and its large directed investments are generally developed proactively.

Grants for Science Research

Discovery Research supports research that generates new knowledge about human life, health and wellbeing. Wellcome takes a broad view of relevant scholarship, funding work in biomedical and clinical science, public health, social science, humanities, ethics, engineering, physical science and other fields when applicants establish a clear connection to health or biology.

Much of Wellcome’s open Discovery Research funding is awarded through three recurring schemes:

  • Wellcome Early-Career Awards support researchers from any discipline who are ready to develop an independent research identity.
    • Awards generally run for five years and cover the applicant’s salary plus up to £400,000 in research expenses, with certain additional costs falling outside that cap. The scheme opens three times a year and does not accept coapplicants.
    • Lead applicants must meet Wellcome’s definition of an early-career researcher and apply through an eligible administering organization.
    • Hosts are generally nonprofit higher education institutions, research institutes or healthcare organizations in the United Kingdom, Republic of Ireland or an eligible low- or middle-income country, excluding India and mainland China.
  • Wellcome Career Development Awards support mid-career researchers who are ready to lead substantial research programs and have the potential to become international leaders in their fields.
    • Awards usually run for eight years. Wellcome does not impose a fixed maximum, but annual spending is normally below £250,000, excluding the applicant’s salary; larger requests receive additional scrutiny. The scheme runs three times a year.
    • Eligible hosts are located in the U.K., Ireland or qualifying LMICs other than India and mainland China.
    • Applicants may come from any discipline, provided their work promises a significant advance in understanding or develops methods, tools or frameworks that benefit health-related research.
  • Wellcome Discovery Awards fund established researchers and teams pursuing ambitious, creative research that could produce a major shift in understanding. Awards can last up to eight years and average about £3.5 million.
    • Applications exceeding £5 million undergo additional scrutiny. The competition normally runs twice a year and permits coapplicants.
    • Current lead-host eligibility includes the U.K., Ireland and eligible LMICs other than India and mainland China.
    • Beginning October 29, 2026, Wellcome plans to limit lead applicants to eligible hosts in the U.K. and LMICs in Africa, South Asia and Southeast Asia.

Grants for Climate Change and Health

Wellcome’s Climate and Health program supports research on how climate change and climate action affect physical and mental health. The funder is particularly interested in evidence that can influence climate policy, improve health outcomes and respond to the needs of populations facing the greatest exposure and vulnerability.

  • The program’s principal recurring opportunity is the annual Climate Impacts Awards. These awards provide up to £2.5 million over three years to transdisciplinary teams combining evidence generation or synthesis with policy engagement and influencing strategies.
  • Applicants may be based anywhere in the world except mainland China, and coapplicants are required. Wellcome prioritizes work involving communities heavily affected by climate-related health risks.
  • This is not a general climate advocacy fund. Competitive projects must identify a specific evidence gap, a realistic policy opportunity and a credible route to influence within the award period.
  • Wellcome has also issued one-time calls related to extreme heat, climate-sensitive infectious disease, mitigation and health co-benefits.
  • Grantseekers should consult the foundation’s live funding-opportunity finder, since these calls change regularly.

Grants for Diseases

The Infectious Disease program supports research that improves understanding of infectious diseases and accelerates the development, evaluation and delivery of interventions. Giving encompasses vaccines, therapeutics, clinical trials, drug-resistant infections, epidemic preparedness, disease modeling and evidence that can change public-health policy or clinical practice.

  • Unlike Discovery Research, this program does not maintain one permanent open competition. Wellcome issues targeted calls tied to specific research gaps and regions. Recent examples include an Infectious Disease Clinical Trial Award, offering £1 million to £8 million for randomized trials led from Africa, South Asia or Southeast Asia, and an accompanying Clinical Trial Development Award, offering up to £200,000 to develop teams, protocols and pilot evidence. Both 2026 rounds are now closed.
  • Other recent calls have addressed dengue and Zika, vaccine efficacy, cholera vaccination and health and disease modeling in Africa.
  • Eligibility, geography and award size vary significantly, so applicants should not assume that the rules governing one infectious-disease call apply to another.

Grants for Mental Health

Wellcome’s Mental Health program focuses on improving early intervention for anxiety, depression and psychosis. It supports research into mechanisms, measurement, treatment matching, scalable interventions and the practical implementation of evidence in real-world settings.

  • Funding is generally awarded through large, time-limited calls rather than one standing mental health scheme.
  • Current and recent opportunities include the Mental Health Award: Transforming Early Intervention, which provides £200,000 for a foundation phase followed by £5 million to £8 million for selected impact-phase projects.
  • Teams must include established research leadership, coapplicants, implementation expertise and meaningful involvement by people with lived experience.
  • Other calls have supported trials of physical-activity and circadian interventions for young people, generative AI, longitudinal data analysis, treatment stratification and novel drug targets. Many permit eligible organizations worldwide other than mainland China, but the scientific scope and team requirements are tightly defined.

Other Opportunities

Wellcome periodically offers cross-program and career-development opportunities beyond its four core program areas.

  • Wellcome Accelerator Awards provide flexible support for U.K.-based researchers of Black, Bangladeshi and Pakistani heritage at important career transitions. Funding may support research as well as training, networking, secondments and other research-adjacent activities.
  • Genomics in Context Awards support transdisciplinary work connecting genomics with humanities, social sciences and bioethics. Wellcome has also launched calls for AI-enabled evidence-synthesis infrastructure and funding for institutions to operate doctoral programs for healthcare professionals. Individual students and fellows generally apply to participating universities rather than directly to Wellcome.
  • Wellcome also makes Discretionary Awards outside its regular calls when it identifies work that advances its strategic objectives. These awards are invitation-only; organizations cannot initiate an application.

Major Initiatives and Related Organizations

Wellcome directs substantial long-term funding to research infrastructure, centers, platforms and major partnerships. These investments provide facilities, technology, data and institutional capacity at a scale that ordinary project grants cannot support. They are generally initiated or developed by Wellcome and should not be treated as open grant programs.

  • Genome Research Limited operates the Wellcome Sanger Institute, a Wellcome subsidiary conducting large-scale genomics research. Sanger receives core support from Wellcome in five-year cycles. It is an operating research institution, not an external application pathway for nonprofits. Its Wellcome Connecting Science initiative provides training, education and public-engagement programming, but is not an independent grantmaker.
  • Wellcome Leap is a separate U.S.-based 501(c)(3) subsidiary that uses an ARPA-style model to fund ambitious, milestone-driven health research. It operates its own programs, calls and funding agreements and supports universities, research institutes, nonprofits and companies when they meet a program’s requirements. Leap currently reports 16 programs operating across 30 countries. There is no general rolling application; prospective performers must follow individual program announcements.

Important Grant Details:

Wellcome reported charitable expenditure of approximately £1.9 billion in 2024–2025, up from £1.6 billion in the prior year. During the same period, it received 4,289 applications and made 711 awards worth a combined £1.3 billion. Its portfolio included 2,723 active grants at 1,443 organizations in 133 countries, with a total value of £7.3 billion.

Grant size varies too widely for a single useful range. Early-Career Awards cover salary and up to £400,000 in research expenses; Discovery Awards average £3.5 million; and targeted calls can range from £200,000 development grants to awards of £8 million or more. Major institutional and infrastructure commitments may be considerably larger.

  • Geography: The U.K. remains the center of Wellcome’s grantmaking. Financial statements for 2024–2025 recorded approximately £1.02 billion in U.K. grants and £387.5 million in directly funded international grants.
  • U.S.-based organizations generally cannot serve as lead hosts for the three core Discovery Research schemes, but they may be eligible for worldwide targeted calls, Wellcome Leap programs or consortium roles when the individual guidelines permit. Applicants should review each opportunity independently rather than relying on Wellcome’s general eligibility page.
  • Wellcome maintains a searchable funded-grants database that can be filtered by program, scheme, organization, geography and keyword.
  • Wellcome does not accept generic letters of inquiry or free-form unsolicited proposals. Applicants must respond to a published scheme or call through the Wellcome Funding platform. Most applications require review and formal submission by an eligible administering organization.

  • Deadlines vary by grant and several granting programs have multiple cycles per year. Grantseekers should familiarize themselves with the application guidelines of their chosen grant before applying.



  • Individual applicants must be sponsored by an eligible host organization, which may be an institute of higher education, research institute, nonprofit, or healthcare organization.


  • To learn more about the trust’s grantees, explore its list of grants awarded.
  • Grantseekers may reach out to Wellcome through its contact form or by phone at +44-(0)20-7611-8888 for further inquiries.

PEOPLE:

Search for staff contact info and bios in PeopleFinder (paid subscribers only).

LINKS:

Last updated on